FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sean Zhao

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Tong J Gan; Girish P Joshi; Sean Z Zhao; D B Hanna; Raymond Y Cheung; Connie Chen
Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects.
Sean Z Zhao; Frances Chung; David B Hanna; Anna L Raymundo; Raymond Y Cheung; Connie Chen
Dose-response relationship between opioid use and adverse effects after ambulatory surgery.
Sean Z Zhao; Chuck Wentworth; Thomas A Burke; Robert W Makuch
Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sean Zhao (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Tong J Gan; Girish P Joshi; Sean Z Zhao; D B Hanna; Raymond Y Cheung; Connie Chen
Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects.
Acta anaesthesiologica Scandinavica 2004;48(9):1194-207.
2004: Sean Z Zhao; Frances Chung; David B Hanna; Anna L Raymundo; Raymond Y Cheung; Connie Chen
Dose-response relationship between opioid use and adverse effects after ambulatory surgery.
Journal of pain and symptom management 2004;28(1):35-46.
2004: Sean Z Zhao; Chuck Wentworth; Thomas A Burke; Robert W Makuch
Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
Pharmacoepidemiology and drug safety 2004;13(5):277-87.
2004: Frederick Wolfe; Kaleb Michaud; Thomas A Burke; Sean Z Zhao
Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
The Journal of rheumatology 2004;31(2):355-8.
2003: Frederick Wolfe; Kaleb Michaud; Sean Z Zhao
Patient perception of the burden of weight gain and blood pressure increase among RA patients using celecoxib, rofecoxib, and non-specific NSAIDs.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2003;9(6):344-53.
2003: Jay L Goldstein; Sean Z Zhao; Thomas A Burke; Ryan Palmer; Heather von Allmen; Scott C Henderson
Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
The American journal of gastroenterology 2003;98(12):2627-34.
2003: Luba Nalysnyk; Kyle Fahrbach; Matthew W Reynolds; Sean Z Zhao; S Ross
Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis.
Heart (British Cardiac Society) 2003;89(7):767-72.
2002: Sean Z Zhao; Thomas A Burke; Andrew Whelton; Heather von Allmen; Scott C Henderson
Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
The American journal of managed care 2002;8(15 Suppl):S414-27.
2002: Sean Z Zhao; Thomas A Burke; Andrew Whelton; Heather von Allmen; Scott C Henderson
Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
The American journal of managed care 2002;8(15 Suppl):S401-13.
2002: Sean Z Zhao; Thomas A Burke; Andrew Whelton; Heather von Allmen; Scott C Henderson
Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
The American journal of managed care 2002;8(15 Suppl):S392-400.
2002: Consuelo Huerta; Sean Z Zhao; Luis Alberto García Rodríguez
Risk of acute liver injury in patients with diabetes.
Pharmacotherapy 2002;22(9):1091-6.
2002: Sean Z Zhao; William E Dodge; William Spalding; Charles Barr; Jim Z Li
Length of hospital stay and cost of Staphylococcus and Streptococcus infections among hospitalized patients.
Clinical therapeutics 2002;24(5):818-34.
2002: Felix M Arellano; Sean Z Zhao; Matthew W Reynolds
Case of cholestatic hepatitis with celecoxib did not fulfil international criteria.
BMJ (Clinical research ed.) 2002;324(7340):789.
2002: Philip S Wang; Raisa Levin; Sean Z Zhao; Jerry Avorn
Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients.
Journal of the American Geriatrics Society 2002;50(1):117-24.
2001: Sean Z Zhao; Matthew W Reynolds; J Lejkowith; Andrew Whelton; F M Arellano
A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Clinical therapeutics 2001;23(9):1478-91.
2001: SK Gandhi; Warren J Salmon; Sean Z Zhao; Bruce L Lambert; P R Gore; Karen M Conrad
Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials.
Clinical therapeutics 2001;23(7):1080-98.
2000: Bruce L Lambert; D N Butin; D Moran; Sean Z Zhao; B C Carr; C Chen; F J Kizis
Arthritis care: comparison of physicians' and patients' views.
Seminars in arthritis and rheumatism 2000;30(2):100-10.
2000: WG Bensen; Sean Z Zhao; Thomas A Burke; RA Zabinski; Robert W Makuch; Clement Maurath; Naurang M Agrawal; G Steven Geis
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
The Journal of rheumatology 2000;27(8):1876-83.
1998: SX Kong; HT Hatoum; Sean Z Zhao; Naurang M Agrawal; S G Geis
Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases.
The American journal of managed care 1998;4(3):399-409.